MIRacle™ hsa-miR-653-5p miRNA Agomir/Antagomir

Description

MIRacle™ hsa-miR-653-5p miRNA Agomir/Antagomir is a chemically modified synthetic oligonucleotide developed to precisely modulate the activity of endogenous microRNAs. The Agomir functions as a miRNA mimic, effectively enhancing the expression and biological activity of hsa-miR-653-5p. Whereas the Antagomir serves as a sequence-specific antagonist, inhibiting hsa-miR-653-5p function. Both formulations are optimized for high stability and efficacy in in vitro and in vivo settings. AcceGen provides the MIRacle™ series in multiple specifications (2 OD, 4 OD, 50 OD) with HPLC purification to accommodate a diverse range of experimental requirements. These reagents are ideal for exploring the biological functions of hsa-miR-653-5p in disease contexts such as prostate cancer metastasis, osteoarthritis progression via chondrocyte senescence regulation, and breast cancer suppression.